Make Innovation and Patients a Priority in 2017:
Repeal the Medical Device Tax
Last year, Congress advanced patient care by temporarily suspending the medical device excise tax – allowing companies to invest in R&D, re-start delayed projects, and create jobs.
We urge Congress to move quickly in 2017 to fully repeal the medical device tax. Doing so will provide certainty for companies making decisions affecting tomorrow’s life-changing medical technologies.
“Simply put, today’s announcement is proof that the medical device tax needs to be permanently repealed so Welch Allyn will remain a source of economic energy for Central New York for years to come.”
“Our continued investment in this collaboration [with the Mayo Clinic] is an example of our commitment to further investing in jobs and innovation as a result of the recent suspension of the medical device tax.”
“This critical relief [from the device tax] is extremely important to BD, as well as the patients, providers and research communities we serve. We are already reinvesting the savings…into a number of R&D projects including medication management and genomics.”
“Suspension of the medical device tax will greatly benefit our patients, who are children. Instead of paying hundreds of thousands of dollars in excise tax, we can now use that money to increase substantially our development of new products that help kids.”
“When I heard…that this excise tax freeze was going through, just last week, I signed the contract with this R&D firm…. I’m going to take that money and I’m going to create jobs.”
“[Thanks to the suspension of the device tax], the company will materially increase its R&D budget in 2016 over 2015. Employees will receive a pay increase above the US and industry average and the largest pay increase in recent memory.”